13-06-2023 | Rivaroxaban
Profibrinolytic effects of rivaroxaban are mediated by thrombin-activatable fibrinolysis inhibitor and are attenuated by a naturally occurring stabilizing mutation in enzyme
Published in: Journal of Thrombosis and Thrombolysis | Issue 2/2023
Login to get access